---
title: "Australia’s drug regulator warns of mental‑health risks for weight‑loss and diabetes drugs"
summary: "Australia’s TGA has added safety notices for the popular weight‑loss and diabetes drugs that act on GLP‑1 receptors (Ozempic, Wegovy, Saxenda, Trulicity, Mounjaro). Doctors should watch patients for new or worsening depression, suicidal thoughts, or mood changes. The regulator also cautions that Mounjaro can reduce the effectiveness of oral birth‑control pills, so people on those pills may need extra protection."
category: General News
section: "Australia news"
imageUrl: "https://media.guim.co.uk/89c36774bb69068904053270f30eebbcc9369362/556_0_5560_4448/500.jpg"
publishedAt: "2025-12-01T07:11:47Z"
guardianId: "australia-news/2025/dec/01/mental-health-warning-issued-for-weight-loss-drugs-including-ozempic-in-australia"
---

Australia’s TGA has added safety notices for the popular weight‑loss and diabetes drugs that act on GLP‑1 receptors (Ozempic, Wegovy, Saxenda, Trulicity, Mounjaro). Doctors should watch patients for new or worsening depression, suicidal thoughts, or mood changes. The regulator also cautions that Mounjaro can reduce the effectiveness of oral birth‑control pills, so people on those pills may need extra protection.
